Antagonist drug selectivity for radioligand binding sites on voltage-gated and N-methyl-D-aspartate receptor-gated Ca2+ channels.

Jaffe DB, Marks SS, Greenberg DA. Antagonist drug selectivity for radioligand binding sites on voltage-gated and N-methyl-D-aspartate receptor-gated Ca2+ channels. Neurosci Lett. 1989 Oct 23; 105(1-2):227-32.

View in: PubMed

subject areas

Animals
Calcium Channel Blockers
Calcium Channels
Cerebral Cortex
Dizocilpine Maleate
Ion Channel Gating
Isradipine
Male
Oxadiazoles
Radioligand Assay
Rats
Rats, Inbred Strains
Receptors, N-Methyl-D-Aspartate

authors with profiles

David Jaffe

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support